OMALIZUMAB
omalizumab 300 mg/2 mL injection, 2 mL pen device
OMALIZUMAB (14952Y)
14952Y
Manner of administration:Injection
Restriction
Indication: Uncontrolled severe asthma
Treatment phase: Balance of supply
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 0 | DPMQ: $418.14 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Xolair | |||||